Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease:
- 1 April 2003
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 64 (4) , 216-235
- https://doi.org/10.1016/s0011-393x(03)00059-6
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Discontinuation syndrome following donepezil cessationInternational Journal of Geriatric Psychiatry, 2003
- Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitorsNeurological Sciences, 2002
- Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 ratsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2002
- Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefitJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2002
- Selective Inhibitors of ButyrylcholinesteraseDrugs & Aging, 2001
- DonepezilPharmacoEconomics, 1999
- Selectivity of Cholinesterase InhibitionCNS Drugs, 1999
- Cholinesterase Inhibitors in the Treatment of Alzheimer??s DiseaseDrug Safety, 1998
- DonepezilDrugs & Aging, 1997
- The Neuropsychiatric InventoryNeurology, 1994